← Back to Vaccine Database

RSV MEDI ΔM2-2

Live attenuated vaccine · VDDBV0661

Target & Classification

RSVRespiratory syncytial virus
Live attenuated vaccine
Respiratory syncytial virus
Phase 1

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials1

NCT IDPhaseDisease / Condition
NCT01459198 Phase 1Respiratory syncytial virus